Weitz & Luxenberg will consider cases from people who lived or worked at Camp Lejeune, for a period of at least 30 cumulative days, sometime between August 1, 1953 and December 31, 1987, and have one or more of the diseases listed below. We will also accept cases of people who were in utero while their mother lived or worked at Camp Lejeune, sometime between August 1, 1953, and December 31, 1987, and have one or more of the diseases listed below.
- Aplastic Anemia
- Bladder
- Brain
- Cardiac Birth Defect
- Cervical Cancer
- Colon Cancer
- Esophageal Cancer
- Fatty Liver Disease (hepatic steatosis)
- Female Breast Cancer
- Hodgkin’s Lymphoma
- Kidney Cancer
- Kidney/Renal Disease – Client must not have a prior diabetes diagnosis
- Kidney/Renal Failure – Client must not have a prior diabetes diagnosisrain
- Larynx Cancer
- Leukemia
- Liver Cancer
- Lung Cancer
- Male breast cancer
- Multiple Myeloma
- Myelodysplastic syndromes
- Non-Cardiac Birth Defect
- Oral Cavity and pharynx cancer
- Ovarian Cancer
- Non-Hodgkin’s Lymphoma
- Parkinson’s disease
- Prostate Cancer
- Prostate Cancer
- Rectal Cancer
- Scleroderma
- Systematic Sclerosis
- Thyroid Cancer
- Female Infertility/Miscarriage – Diagnosis/miscarriage on base or within 6 months of being on base. Includes miscarriage at <19 weeks and fetal death at >20 weeks
NOTE: This list may be amended as more information is published about health outcomes from exposure to the chemicals in the drinking water at Camp Lejeune during the relevant time period.
National Headquarters
700 Broadway / New York NY 10003
Branch offices located in New Jersey, California & Michigan
Attorney Advertising.
Prior results do not guarantee a future outcome.
By clicking “Submit”, you agree that you have read and agree to our privacy policy and terms of use and that the phone number and email address you are providing express written consent to be contacted by Weitz & Luxenberg P.C., even if you are on a state/federal do-not-call registry (including auto-dialed/auto-selected and prerecorded calls, as well as text/SMS messages – message and data rates may apply). To opt-out of the disclosure of your information, please click here. Your consent to such contact is not required. To proceed without providing consent please call us at 856-755-1115. We may also e-mail you, and you may let us know at any time if you are no longer interested in hearing from us via a particular communication platform. Due to the importance of your inquiry, you also specifically request that we contact you, if necessary, outside the permissible call time restrictions of applicable state and federal laws.